» Authors » Aneta Plaza-Altamer

Aneta Plaza-Altamer

Explore the profile of Aneta Plaza-Altamer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 32
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolodziej A, Plaza-Altamer A
Talanta . 2024 Jun; 277:126347. PMID: 38838565
Silver nanoparticles are used in laser mass spectrometry to replace organic matrices. Thanks to their unique properties, they enable effective desorption/ionization of samples of various polarities and ionization abilities. This...
2.
Ossolinski K, Ruman T, Copie V, Tripet B, Kolodziej A, Plaza-Altamer A, et al.
Metabolomics . 2024 Jan; 20(1):14. PMID: 38267657
Introduction: Bladder cancer is a common malignancy affecting the urinary tract and effective biomarkers and for which monitoring therapeutic interventions have yet to be identified. Objectives: Major aim of this...
3.
Niziol J, Ossolinski K, Plaza-Altamer A, Kolodziej A, Ossolinska A, Ossolinski T, et al.
J Pharm Biomed Anal . 2024 Jan; 240:115966. PMID: 38217999
Bladder cancer (BC) ranks among the most common cancers globally, with an increasing occurrence, particularly in developed nations. Utilizing tissue metabolomics presents a promising strategy for identifying potential biomarkers for...
4.
Plaza-Altamer A, Kolodziej A, Krupa Z, Niziol J, Ruman T
Rapid Commun Mass Spectrom . 2023 Sep; 37(20):e9621. PMID: 37706428
Rationale: Hormones are compounds that perform many important functions in the human body, but above all their task is to maintain homeostasis by adapting them to the constantly changing environmental...
5.
Niziol J, Ossolinski K, Plaza-Altamer A, Kolodziej A, Ossolinska A, Ossolinski T, et al.
Sci Rep . 2023 Jun; 13(1):9802. PMID: 37328580
Bladder cancer (BC) is a common urological malignancy with a high probability of death and recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient monitoring for...
6.
Ossolinski K, Ruman T, Copie V, Tripet B, Kolodziej A, Plaza-Altamer A, et al.
J Pharm Biomed Anal . 2023 May; 233:115473. PMID: 37229797
Bladder cancer (BC) is frequent cancer affecting the urinary tract and is one of the most prevalent malignancies worldwide. No biomarkers that can be used for effective monitoring of therapeutic...
7.
Ossolinski K, Ruman T, Copie V, Tripet B, Nogueira L, Nogueira K, et al.
J Pharm Anal . 2023 Jan; 12(6):889-900. PMID: 36605581
Bladder cancer (BC) is one of the most frequently diagnosed types of urinary cancer. Despite advances in treatment methods, no specific biomarkers are currently in use. Targeted and untargeted profiling...
8.
Ossolinski K, Ruman T, Ossolinski T, Ossolinska A, Arendowski A, Kolodziej A, et al.
Adv Med Sci . 2022 Dec; 68(1):38-45. PMID: 36566601
Purpose: Bladder cancer (BC) is the 10th most common form of cancer worldwide and the 2nd most common cancer of the urinary tract after prostate cancer, taking into account both...
9.
Niziol J, Ossolinski K, Plaza-Altamer A, Kolodziej A, Ossolinska A, Ossolinski T, et al.
Sci Rep . 2022 Sep; 12(1):15156. PMID: 36071106
Bladder cancer (BC) is a common urological cancer of high mortality and recurrence rates. Currently, cystoscopy is performed as standard examination for the diagnosis and subsequent monitoring for recurrence of...
10.
Kolodziej A, Plaza-Altamer A, Niziol J, Ruman T
Rapid Commun Mass Spectrom . 2022 Aug; 36(21):e9375. PMID: 35933593
Rationale: 3-Hydroxycarboxylic acids are one of the major components of bacterial lipopolysaccharides (LPS), also known as endotoxins. Endotoxins pose a serious health risk and can seriously damage the internal organs...